BR112018074190A2 - antagonistas de receptor de angiotensina 1 - Google Patents
antagonistas de receptor de angiotensina 1Info
- Publication number
- BR112018074190A2 BR112018074190A2 BR112018074190A BR112018074190A BR112018074190A2 BR 112018074190 A2 BR112018074190 A2 BR 112018074190A2 BR 112018074190 A BR112018074190 A BR 112018074190A BR 112018074190 A BR112018074190 A BR 112018074190A BR 112018074190 A2 BR112018074190 A2 BR 112018074190A2
- Authority
- BR
- Brazil
- Prior art keywords
- angiotensin
- receptor antagonists
- pregnancy
- compounds
- formula
- Prior art date
Links
- 101800000734 Angiotensin-1 Proteins 0.000 title 1
- 102400000344 Angiotensin-1 Human genes 0.000 title 1
- 239000002464 receptor antagonist Substances 0.000 title 1
- 229940044551 receptor antagonist Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 206010070538 Gestational hypertension Diseases 0.000 abstract 1
- 201000005624 HELLP Syndrome Diseases 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 208000005347 Pregnancy-Induced Hypertension Diseases 0.000 abstract 1
- 208000017169 kidney disease Diseases 0.000 abstract 1
- 201000011461 pre-eclampsia Diseases 0.000 abstract 1
- 208000036335 preeclampsia/eclampsia 1 Diseases 0.000 abstract 1
- 230000035935 pregnancy Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/14—Angiotensins: Related peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
a presente invenção refere-se a compostos de fórmula (i) ou um sal farmaceuticamente aceitável dos mesmos: aa1-arg-val-aa4-aa5-his-pro-aa8-oh (i), nos quais aa1, aa4, aa5, e aa8 são definidos no relatório descritivo. os compostos de fórmula (i) podem ser usados para tratar hipertensão (por exemplo, hipertensão induzida por gravidez), pré-eclâmpsia, ou uma doença renal induzida por gravidez.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662344831P | 2016-06-02 | 2016-06-02 | |
| EP16185403 | 2016-08-23 | ||
| PCT/EP2017/063455 WO2017207760A1 (en) | 2016-06-02 | 2017-06-02 | Angiotensin-1-receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112018074190A2 true BR112018074190A2 (pt) | 2019-03-26 |
Family
ID=58992873
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112018074190A BR112018074190A2 (pt) | 2016-06-02 | 2017-06-02 | antagonistas de receptor de angiotensina 1 |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP3464324B1 (pt) |
| JP (1) | JP7139251B2 (pt) |
| BR (1) | BR112018074190A2 (pt) |
| CL (1) | CL2018003324A1 (pt) |
| DK (1) | DK3464324T3 (pt) |
| ES (1) | ES2878153T3 (pt) |
| HU (1) | HUE054334T2 (pt) |
| IL (1) | IL262981B2 (pt) |
| JO (1) | JOP20170133B1 (pt) |
| MX (1) | MX2018014364A (pt) |
| MY (1) | MY191062A (pt) |
| PH (1) | PH12018502440A1 (pt) |
| PL (1) | PL3464324T3 (pt) |
| SI (1) | SI3464324T1 (pt) |
| UA (1) | UA123367C2 (pt) |
| ZA (1) | ZA201807767B (pt) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2376101T3 (en) | 2008-12-29 | 2016-01-18 | Trevena Inc | BETA-arrestin effectors AND COMPOSITIONS AND METHODS FOR USE THEREOF |
-
2017
- 2017-05-29 JO JOP/2017/0133A patent/JOP20170133B1/ar active
- 2017-06-02 UA UAA201812609A patent/UA123367C2/uk unknown
- 2017-06-02 JP JP2018561231A patent/JP7139251B2/ja active Active
- 2017-06-02 IL IL262981A patent/IL262981B2/en unknown
- 2017-06-02 ES ES17727220T patent/ES2878153T3/es active Active
- 2017-06-02 SI SI201730820T patent/SI3464324T1/sl unknown
- 2017-06-02 MX MX2018014364A patent/MX2018014364A/es unknown
- 2017-06-02 PL PL17727220T patent/PL3464324T3/pl unknown
- 2017-06-02 HU HUE17727220A patent/HUE054334T2/hu unknown
- 2017-06-02 BR BR112018074190A patent/BR112018074190A2/pt not_active Application Discontinuation
- 2017-06-02 MY MYPI2018002027A patent/MY191062A/en unknown
- 2017-06-02 DK DK17727220.0T patent/DK3464324T3/da active
- 2017-06-02 EP EP17727220.0A patent/EP3464324B1/en active Active
-
2018
- 2018-11-19 ZA ZA2018/07767A patent/ZA201807767B/en unknown
- 2018-11-20 PH PH12018502440A patent/PH12018502440A1/en unknown
- 2018-11-22 CL CL2018003324A patent/CL2018003324A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2018014364A (es) | 2019-02-14 |
| HUE054334T2 (hu) | 2021-08-30 |
| JOP20170133B1 (ar) | 2022-03-14 |
| IL262981B1 (en) | 2023-09-01 |
| PL3464324T3 (pl) | 2021-10-25 |
| IL262981B2 (en) | 2024-01-01 |
| PH12018502440A1 (en) | 2019-09-09 |
| SI3464324T1 (sl) | 2021-08-31 |
| ZA201807767B (en) | 2023-04-26 |
| UA123367C2 (uk) | 2021-03-24 |
| MY191062A (en) | 2022-05-30 |
| CL2018003324A1 (es) | 2019-06-07 |
| ES2878153T3 (es) | 2021-11-18 |
| EP3464324B1 (en) | 2021-04-07 |
| DK3464324T3 (da) | 2021-06-28 |
| JP2019520331A (ja) | 2019-07-18 |
| EP3464324A1 (en) | 2019-04-10 |
| JP7139251B2 (ja) | 2022-09-20 |
| IL262981A (en) | 2018-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA202092896A1 (ru) | Гетероциклические и гетероарильные соединения для лечения болезни гентингтона | |
| MA43763B1 (fr) | Protéine f de pré-fusion du vrs soluble et stabilisée pour son utilisation dans la prophylaxie d'une infection vrs | |
| ZA201801083B (en) | Single domain antibody for programmed death-ligand (pd-l1) and derived protein thereof | |
| EA202092580A1 (ru) | Соединения, ингибирующие rip1, а также способы их получения и применения | |
| EA202091710A1 (ru) | Антитела против cd73 и способы их применения | |
| BR112015029455A8 (pt) | compostos químicos, uso, métodos e composições para prevenção ou tratamento de câncer | |
| CL2015000578A1 (es) | Compuesto n-(2-(6-fluoro-1-h-indol-3-il)etil)-3-(2,2,3,3-tetrafluoropropoxi)bencilamina o su sal, antagonista del receptor 5-ht6; composicion farmaceutica; uso en el tratamiento de la enfermedad de alzheimer. | |
| BR122018070836A8 (pt) | Compostos de amidas heterocíclicas moduladoras de sting, composição contendo ditos compostos e uso dos mesmos para tratar uma doença mediada por sting | |
| EA201890866A1 (ru) | Связывающие молекулы, которые ингибируют рост рака | |
| EA201790492A1 (ru) | СОЕДИНЕНИЯ, КОТОРЫЕ ИНГИБИРУЮТ БЕЛОК Mcl-1 | |
| EA201991697A1 (ru) | Сульфоксиминовые ингибиторы гликозидазы | |
| EA201791002A1 (ru) | Новые соединения, модулирующие fxr (nr1h4) | |
| EA201890278A1 (ru) | Антитела к pd-l1 | |
| WO2015184349A3 (en) | Multivalent ras binding compounds | |
| EA201790740A1 (ru) | Индолкарбоксамидные соединения | |
| EA201891974A1 (ru) | Ингибиторы связывания белка wdr5 с белками | |
| EA202091115A1 (ru) | Производные хиназолина, применяемые для лечения вич | |
| EA201890899A1 (ru) | Модуляторы фарнезоидного x-рецептора | |
| BR112022007612A2 (pt) | Inibidores de raf quinases | |
| EA201892436A1 (ru) | Пиримидиновые соединения в качестве ингибиторов jak киназы | |
| MA45207A (fr) | Stérol brut utilisé comme additif dans un liant d'asphalte | |
| EA201891143A1 (ru) | Пиперидиноновые агонисты формилпептидного рецептора 2 и формилпептидного рецептора 1 | |
| UA113658C2 (xx) | Кристалічна форма і дималеатного інгібітору тирозинкінази і способи її одержання | |
| WO2015171558A3 (en) | BENZENESULFONAMIDO AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORγ AND THE TREATEMENT OF DISEASE | |
| EA201890198A1 (ru) | Новые белки, специфичные в отношении lag-3 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
| B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] | ||
| B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |